Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Molecular Biotechnology|February 10, 2010
Production of a soluble disulfide bond-linked TCR in the cytoplasm of Escherichia coli trxB gor mutantsNathaniel Liddy, Peter E Molloy, Alan D Bennett, et al.European Journal of Immunology|September 6, 2012
Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategiesMilos Aleksic, Nathaniel Liddy, Peter E Molloy, et al.Nature Biotechnology|February 22, 2005
Directed evolution of human T-cell receptors with picomolar affinities by phage displayYi Li, Ruth Moysey, Peter E Molloy, et al.Blood|February 10, 2012
TCR affinity and specificity requirements for human regulatory T-cell functionGabriela Plesa, Lingjie Zheng, Andrew Medvec, et al.The Journal of Biological Chemistry|May 24, 2013
T-cell receptor specificity maintained by altered thermodynamicsFlorian Madura, Pierre J Rizkallah, Kim M Miles, et al.Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.Molecular Cancer Therapeutics|July 11, 2007
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptorMarco A Purbhoo, Yi Li, Deborah H Sutton, et al.The Journal of Biological Chemistry|November 8, 2013
T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactionsDavid K Cole, Kim M Miles, Florian Madura, et al.European Journal of Immunology|May 16, 2019
TCR-induced alteration of primary MHC peptide anchor residueFlorian Madura, Pierre J Rizkallah, Mateusz Legut, et al.Nature Communications|September 10, 2022
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigenAndrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, et al.Pageof 2